BrainStorm Cell Therapeutics Reports Third Quarter 2015 Financial Results And Provides Corporate Update

Go back to BrainStorm Cell Therapeutics Reports Third Quarter 2015 Financial Results And Provides Corporate Update
Brainstorm Cell Therapeutics, Inc. (NASDAQ: BCLI) Delayed: 1.17 --0 (-0%)
Previous Close $1.17    52 Week High $3.87 
Open $1.17    52 Week Low $1.90 
Day High $1.17    P/E N/A 
Day Low $1.17    EPS $-0.03 
Volume 24,235